UTAH MEDICAL PRODUCTS INC
UTMDUS売上高
$39M
百万USD
営業利益
$11M
百万USD
純利益
-
百万USD
ROE
-
最新FY
EPS
$3.48
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $11M | - | $0.83 |
| FY2021 | Q2 | $13M | - | $0.94 |
| FY2021 | Q3 | $13M | - | $1.15 |
| FY2021 | FY | $49M | - | $4.04 |
| FY2022 | Q1 | $12M | - | $0.96 |
| FY2022 | Q2 | $13M | - | $1.12 |
| FY2022 | Q3 | $13M | - | $1.18 |
| FY2022 | FY | $52M | - | $4.52 |
| FY2023 | Q1 | $13M | - | $1.16 |
| FY2023 | Q2 | $13M | - | $1.15 |
| FY2023 | Q3 | $13M | - | $1.08 |
| FY2023 | FY | $50M | - | $4.57 |
| FY2024 | Q1 | $11M | - | $1.09 |
| FY2024 | Q2 | $10M | - | $0.98 |
| FY2024 | Q3 | $10M | - | $1.02 |
| FY2024 | FY | $41M | - | $3.96 |
| FY2025 | Q1 | $10M | - | $0.92 |
| FY2025 | Q2 | $10M | - | $0.94 |
| FY2025 | Q3 | $10M | - | $0.82 |
| FY2025 | FY | $39M | - | $3.48 |
| FY2026 | Q1 | $9M | - | $0.82 |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | $42M | $47M | $42M | $49M | $52M | $50M | $41M | $39M |
| 営業利益 | $16M | $19M | $19M | $18M | $14M | $19M | $20M | $17M | $14M | $11M |
| 純利益 | - | - | - | - | - | - | - | - | - | - |
| 総資産 | $77M | $93M | $100M | $110M | $112M | $116M | $124M | $135M | $123M | $123M |
| 純資産 | - | - | $89M | $101M | $103M | $107M | $114M | $128M | $117M | $119M |
| 自己資本 | $69M | $78M | $89M | $101M | $103M | $107M | $114M | $128M | $117M | $119M |
| 営業CF | $15M | $17M | $17M | $17M | $20M | $21M | $21M | $22M | $15M | $15M |
| EPS | $3.22 | $2.28 | $4.95 | $3.94 | $2.94 | $4.04 | $4.52 | $4.57 | $3.96 | $3.48 |
| BPS | $18.64 | $20.97 | $23.91 | $27.34 | $28.20 | $29.31 | $31.49 | $35.75 | $35.78 | $37.45 |
| ROE | - | - | - | - | - | - | - | - | - | - |